News and Publications

Ten new ASTRO Fellows named in 10th anniversary of FASTRO designation

ARLINGTON, Va., July 6, 2016

Ten distinguished members of the American Society for Radiation Oncology (ASTRO) have been named ASTRO Fellows, in the 10th anniversary year that the designation has been awarded. The 2016 class of Fellows will be recognized at an awards ceremony during ASTRO’s 58th Annual Meeting, to be held September 25-28, 2016, in Boston.

The ASTRO Fellows designation, or FASTRO, honors individuals who have significantly added to the field of radiation oncology in the areas of research, education, patient care or service and leadership. Designees also have been an active or emeritus member of ASTRO for at least 15 years, giving the equivalent of 10 years of service to ASTRO through committee service and similar activities. With the addition of the 2016 class, a total of 269 ASTRO members have received the FASTRO designation since the inception of the award in 2006. 

“The individuals in this class of ASTRO Fellows demonstrate both talent and commitment across multiple aspects of radiation oncology, particularly in clinical care, research, service and education,” said ASTRO Chair Bruce D. Minsky, MD, FASTRO. “As is the case for our other Fellows, the clinicians and researchers in the 2016 cohort show a clear dedication to improving patients’ lives and advancing our field, especially through service to ASTRO and its initiatives.”

The new ASTRO Fellows include:

  • H. Joseph Barthold, MD, Beth Israel Deaconess Hospital-Plymouth, Plymouth, Massachusetts
  • Jennifer R. Bellon, MD, Dana-Farber Cancer Institute, Harvard Medical School, Boston
  • Laura A. Dawson, MD, Princess Margaret Cancer Centre, University of Toronto, Toronto
  • Theodore L. DeWeese, MD, Johns Hopkins University, Baltimore
  • Shalom Kalnicki, MD, Montefiore Medical Center, Albert Einstein College of Medicine, New York
  • Nancy P. Mendenhall, MD, University of Florida, Gainesville, Florida
  • William M. Mendenhall, MD, University of Florida, Gainesville, Florida
  • Todd Pawlicki, PhD, University of California San Diego, La Jolla, California
  • Timothy D. Solberg, PhD, University of California San Francisco, San Francisco
  • John H. Suh, MD, Cleveland Clinic, Cleveland

ASTRO’s 58th Annual Meeting, the nation’s premier scientific meeting in radiation oncology, will be held September 25-28, 2016, at the Boston Convention and Exhibition Center in Boston, Massachusetts. The 2016 Annual Meeting is expected to attract more than 11,000 attendees from across the globe, including oncologists from all disciplines and members of the entire radiation oncology team. Led by ASTRO President David C. Beyer, MD, FASTRO, the 2016 meeting will feature keynote addresses from Kathleen Sebelius, former U.S. Secretary of Health and Human Services; Thomas James Lynch Jr., MD, Chair and CEO, Massachusetts General Physicians Organization; and Jason Ragogna, general manager, SMS and Safety Alliances, Corporate Safety, Security, and Compliance, Delta Air Lines, Inc. The Presidential Symposium, “Prostate Cancer: Defining Value and Delivering It,” highlights the meeting’s theme of “Enhancing Value, Improving Outcomes” and will feature recent practice-changing studies and current developments in value-based care for prostate cancer. ASTRO’s four-day scientific meeting will feature a record number of abstracts, including 368 oral presentations, 1,760 posters and 180 digital posters in more than 50 educational sessions and 20 scientific panels for 20 disease-site tracks. For more information about ASTRO’s 58th Annual Meeting, visit For press registration and news briefing information for ASTRO’s 58th Annual Meeting, visit

For more information, contact Liz Gardner, Media Relations Manager, or Erin L. Boyle, Communications Manager.


ASTRO is the premier radiation oncology society in the world, with more than 10,000 members who are physicians, nurses, biologists, physicists, radiation therapists, dosimetrists and other health care professionals who specialize in treating patients with radiation therapies. As the leading organization in radiation oncology, the Society is dedicated to improving patient care through professional education and training, support for clinical practice and health policy standards, advancement of science and research, and advocacy. ASTRO publishes three medical journals, International Journal of Radiation Oncology • Biology • Physics (, Practical Radiation Oncology ( and Advances in Radiation Oncology (; developed and maintains an extensive patient website, RT Answers (; and created the Radiation Oncology Institute (, a nonprofit foundation to support research and education efforts around the world that enhance and confirm the critical role of radiation therapy in improving cancer treatment. To learn more about ASTRO, visit

We have recently updated our privacy policy and terms of use.
By using this site, you agree to ASTRO’s Privacy Policy and Terms of Use.
We use cookies to provide, secure and improve our services to you. To learn more, click here.